← 返回前沿论文

多发性骨髓瘤患者接受 idecabtagene vicleucel 治疗后出现帕金森样迟发性神经毒性:临床病理、脑脊液及尸检分析

英文原题:Parkinsonism-like delayed neurotoxicity after idecabtagene vicleucel therapy for multiple myeloma: clinicopathological, cerebrospinal fluid, and autopsy analyses.

查看英文原题

Parkinsonism-like delayed neurotoxicity after idecabtagene vicleucel therapy for multiple myeloma: clinicopathological, cerebrospinal fluid, and autopsy analyses.

PubMed 2026/08/27(内容时间) Haematologica Q1 · IF 8.2(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

暂无。

展开英文摘要原文

Not available.

论文信息

作者
Yoshino H、Imi T、Nukii Y、Hosokawa K、Yamada S、Nakagawa S、Higashi D、Sakai S
第一作者单位
Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641.
通讯作者单位
Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan; Faculty of Transdisciplinary Sciences for Innovation, Institute of Transdisciplinary Sciences for Innovation, Kanazawa University, Kakumamachi, Kanazawa, Ishikawa. takamaz@staff.kanazawa-u.ac.jp.Japan
期刊
Haematologica2026 Aug 27
原文标识
PubMed 42657922 · DOI 10.3324/haematol.2026.300852